Search Results - "Englund, Simon"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2

    Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy by Englund, Simon, Frisell, Thomas, Qu, Ying, Gandhi, Kavita, Hultén, Annika, Kierkegaard, Marie, Piehl, Fredrik, Longinetti, Elisa

    “…BackgroundWe analysed the COMparison Between All immunoTherapies for Multiple Sclerosis (NCT03193866), a Swedish nationwide observational study in…”
    Get full text
    Journal Article
  3. 3

    Risk of depression in multiple sclerosis across disease-modifying therapies by Longinetti, Elisa, Frisell, Thomas, Englund, Simon, Reutfors, Johan, Fang, Fang, Piehl, Fredrik

    Published in Multiple sclerosis (01-04-2022)
    “…Background: Depression and use of antidepressants are more common among patients with multiple sclerosis (MS) compared to the general population, but the…”
    Get full text
    Journal Article
  4. 4

    Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study by Fink, Katharina, Gorczyca, Agnes, Alping, Peter, Englund, Simon, Farmand, Susan, Langer-Gould, Annette M, Piehl, Fredrik, McKay, Kyla, Frisell, Thomas, Razaz, Neda

    Published in Multiple sclerosis (01-05-2023)
    “…Background: There is a paucity of information on maternal multiple sclerosis (MS) and risk of adverse pregnancy and perinatal outcomes. Objective: The aim of…”
    Get full text
    Journal Article
  5. 5

    Can health behaviours prolong survival and compress the period of survival with the disability? A population-based cohort study by Wu, Wei, Xu, Weili, Englund, Simon, Shang, Ying, Pan, Kuan-Yu, Rizzuto, Debora

    Published in Age and ageing (01-03-2021)
    “…Abstract Background It remains unclear whether and to what extent health behaviours may prolong survival and compress the period of survival with disability…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden by McKay, Kyla A, Piehl, Fredrik, Englund, Simon, He, Anna, Langer-Gould, Annette, Hillert, Jan, Frisell, Thomas

    Published in JAMA network open (01-12-2021)
    “…This case-control study examines the risk of severe COVID-19 infection in individuals with multiple sclerosis who were receiving rituximab…”
    Get full text
    Journal Article
  9. 9